Datasetspublic full text
ClinicalTrials.gov
clinicaltrials · Datasets · License: Public Domain
186,442Documents
1,450Full text
2026-10-02Last indexed
Recent documents from this source
- Acinetobacter Baumannii-related Osteomyelitis: Clinical and Epidemiological Characterization#127619
- Peritoneal Diffusion and Efficacy of Antibiotic Therapy in Pediatric Peritonitis#127618
- Nosocomial Infections During Total Prostatic Cystectomies (TPC) With Replacement Enterocystoplasty: Prophylactic Role of Urell®, Cranberry Fruit Juice Extract (Vaccicium Macrocarpon)#127617
- Project PROTECT: Protecting Nursing Homes From Infections and Hospitalization#127616
- Personalised Risk Assessment in Febrile Illness to Optimise Real-life Management Across the European Union (PERFORM)#127615
- Safety and Pharmacokinetics of Piperacillin-tazobactam Extended Infusion in Infants and Children (PIP-TAZO)#127614
- CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients#127613
- Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma#127612
- Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer#127611
- Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study#127610
- Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant#127609
- Analysis of Circulating Tumor Markers in Blood#127608
- Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma#127607
- Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer#127606
- Radiotherapy for Extracranial Oligometastatic Breast Cancer#127605
- Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of an Anti-PD-1 mAb for Patients With Advanced Solid Tumors#127604
- Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma#127603
- A Prospective, Open-label, Exploratory Basket Trial to Evaluate the Efficacy and Safety of Sintilimab Combined With Pyrotinib ± Chemotherapy in Patients With Advanced Digestive System Tumors#127602
- Neoadjuvant Immunotherapy to ESCC#127601
- Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC#127600
Source record · clinicaltrials · Datasets · License: Public Domain
Conceptio Open Knowledge Archive — counts are materialised per sync from the index (real full-text coverage, never license entitlement).